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AbsTRACT
The Hedgehog (Hh) signaling pathway is a key regulator of both embryonic develop‑
ment and homeostasis of adult tissues, including thymus and blood. In the thymus, Hh 
signals for differentiation, survival and proliferation in the early stages of T cell develop‑
ment, before TCR gene rearrangement. Our recent data has shown that Hh signaling also 
modulates T cell receptor (TCR) signal strength in more mature T lineage cells. We showed 
that constitutive activation of the Hh pathway in thymocytes (by transgenic expression of 
the transcriptional activator form of Gli2) decreased TCR signal strength with profound 
consequences for the thymus—allowing self‑reactive T cells to escape deletion and 
altering T cell CD4/CD8 lineage decisions. In contrast, in the Sonic Hh deficient thymus, 
TCR signaling was increased, again influencing both TCR repertoire selection and 
CD4/8 lineage commitment. In peripheral T cells, the transcriptional changes induced 
by activation of the Hh signaling pathway lead to reduced T cell activation. Hh signaling 
also attenuated ERK phosphorylation and proliferation in mature T cells on TCR ligation. 
Modulation of TCR signal strength by Hh pathway activation has importance for immunity 
as the presence or absence of Hh in the environment in which a T cell is activated would 
shape the immune response.
INTRoduCTIoN
The	hedgehog	(Hh)	family	of	secreted	intercellular	signaling	molecules	(Sonic,	Indian	
and	Desert	Hh)	modulate	 target	 gene	 expression	 via	 the	Gli	 transcription	 factors.	Hh	
proteins	 are	 essential	 morphogens	 during	 embryogenesis	 and	 the	 homeostasis	 of	 adult	
tissues,1-4	 and	 can	 influence	 differentiation,	 cell	 cycle	 progression	 and	 survival.1,5	 In	 a	
classical	model,	a	morphogen	specifies	cell	fate	by	establishment	of	a	morphogen	gradient,	
in	 which	 its	 movement	 from	 a	 polarised	 source	 provides	 positional	 information	 for	
patterning	and	differentiation	in	a	solid	tissue.	In	addition	to	its	competence	to	transduce	
the	signal,	the	response	of	the	receiving	cell	depends	on	the	concentration	and	duration	of	
the	signal	received	and	therefore	on	its	position	in	the	tissue.	In	contrast	to	organogenesis	
of	solid	tissues,	 the	 immune	system	is	 ‘fluid’,	made	up	of	multiple	cell	 types	that	move	
through	the	body	and	interact,	differentiate	and	respond	in	many	different	environments.	
Despite	 this	 apparent	 difference,	Hh	 signaling	has	 also	 turned	 out	 to	 be	 an	 important	
regulator	of	the	immune	system.2,6-12
The	Gli	 transcription	 factors	 (Gli1,	Gli2	 and	Gli3)	 are	 key	 to	 the	 interpretation	 of	
the	Hh	gradient	by	the	receiving	cell.1,5	They	have	distinct	temporal	and	tissue-specific	
expression	 patterns	 and	 functions.	Gli2	 is	 necessary	 to	 initiate	 the	 first	 transcriptional	
changes	induced	by	Hh	signaling.13	Gli1	is	solely	an	activator	of	transcription,	but	Gli2	
and	Gli3	 can	be	processed	 to	 activate	or	 repress	 target-gene	 transcription,	 according	 to	
the	presence	or	absence	of	Hh	respectively.13-16	Gli	functions	are	affected	by	their	cellular	
context,	and	are	dependent	both	on	cell	type	and	the	Hh	environment	of	that	cell.17,18	
The	interpretation	of	the	Hh	signal	in	a	given	cell	relies	on	the	balance	of	activator	and	
repressor	forms	of	Gli	proteins	produced.
HH sIgNALINg IN THe THymus
The	specialised	environment	of	the	thymus	supports	the	maturation	of	haematopoietic	
progenitors	 into	 functional	 T	 lymphocytes	 and	 this	 involves	 bi-directional	 signaling	
between	the	thymic	epithelium	and	developing	thymocytes.	During	T	cell	development,	
thymocytes	 pass	 through	 stages	 that	 can	 be	 defined	 by	 the	 expression	 of	 cell	 surface	
markers:	 CD4-CD8-	 double	 negative	 (DN)	 cells	 differentiate	 into	CD4+CD8+	 double	
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positive	 (DP)	 thymocytes,	 which	 mature	 to	 become	 CD4	 single	
positive	 (SP)	 and	 CD8	 SP	 thymocytes.	 Signaling	 by	 a	 functional	
pre-T	 cell	 receptor	 (pre-TCR)	 is	 necessary	 for	 differentiation	 from	
DN	to	DP	cell.19	Maturation	from	DP	to	SP	cell	requires	the	expres-
sion	 of	 a	 functional,	 MHC-restricted	 abTCR	 and	 involves	 TCR	
repertoire	selection.20,21	Positive	selection	of	thymocytes	that	express	
TCR	 with	 appropriate	 affinity	 for	 self-MHC	 molecules	 ensures	
functional	self-restriction,	while	negative	selection	of	thymocytes	that	
express	TCR	with	high	affinity	for	self	removes	overtly	self-reactive	
T	cell	clones;	therefore	cell	fate	is	at	least	in	part	determined	by	the	
strength	of	the	signal	transduced	by	the	TCR.21	Mature	T	cells	then	
exit	the	thymus	to	populate	peripheral	lymphoid	organs	where	they	
can	be	 activated	 on	TCR	binding	 to	peptide	 antigen	presented	by	
major	 histocompatibility	 complex	 (MHC)	molecules.	CD4	T	 cells	
recognise	 antigen	 as	 peptide	 in	 the	 context	 of	 self	MHC	Class	 II	
molecules,	whereas	CD8	T	cells	recognise	antigen	as	peptide	in	the	
context	of	self	MHC	Class	I	molecules.
Hh	signaling	is	important	in	T	cell	development,	in	both	humans	
and	 mice.2,6,7,9-12	 Shh	 is	 expressed	 by	 thymic	 epithelial	 cells	 and	
components	 of	 the	 Hh	 signaling	 pathway	 are	 expressed	 in	 the	
lymphoid	 and	 stromal	 compartments	 of	 the	 thymus.2,6,9,11,12	 Hh	
signaling	is	involved	in	the	homeostasis	of	DN	cells,	differentiation	
from	DN1	to	DN26,7,10,11	and	the	DN	to	DP	transition.2,7,10,11
We	 have	 recently	 investigated	 the	 function	 of	 Hh	 signaling	 at	
later	stages	of	murine	thymocyte	development.	We	have	shown	that	
Hh	signaling	is	involved	in	the	maturation	of	immature	DP	cells	to	
mature	SP	thymocytes	and	that	it	can	affect	TCR	repertoire	selection	
and	CD4/8	lineage	choice.12
HH sIgNALINg ALTeRs TCR RepeRToIRe seLeCTIoN 
ANd Cd4:Cd8 RATIo IN deveLopINg THymoCyTes
We	 produced	 transgenic	 mice	 with	 a	 transcriptional	 activator	
form	 of	 the	 Gli2	 protein	 (Gli2DN2)14	 under	 the	 control	 of	 the	
T-lineage-restricted	Lck	promoter.22,23	This	Lck-Gli2DN2	transgene	
induces	the	transcriptional	events	normally	caused	by	active	Hh	sign-
aling,	allowing	us	to	assess	the	effect	of	constitutive	activation	of	the	
Hh	signaling	pathway	specifically	in	T	cells.
Expression	of	the	Lck-Gli2DN2	transgene	decreased	the	produc-
tion	 of	 CD4	 SP	 cells	 in	 the	 thymus,	 and	 reduced	 the	 CD4:CD8	
ratio.	Treatment	 of	 wild	 type	 (WT)	 thymus	 explants	 with	 recom-
binant	 Shh	 protein	 (r-Shh)	 also	 decreased	 the	 CD4:CD8	 ratio,	
confirming	 that	 Hh	 can	 influence	 the	 CD4/8	 lineage	 decision.	
Conversely,	 analysis	 of	 Shh-/-	 thymi	 showed	 increased	 production	
of	CD4	SP	cells	and	the	CD4:CD8	ratio,	confirming	that	Hh	sign-
aling,	and	Shh	in	particular,	does	affect	CD4/8	lineage	commitment	
under	 physiological	 conditions	 (Fig.	 1A).	Commitment	 of	 the	DP	
population	 to	 the	CD4	or	CD8	 lineage	 is	 complicated	by	 the	 fact	
that	the	mature	CD4	and	CD8	cells	must	express	TCR	restricted	by	
the	appropriate	MHC	molecule	(by	Class	I	 in	the	case	of	CD8	SP	
cells,	and	by	Class	II	in	the	case	of	CD4	SP	cells).	Numerous	models	
have	been	proposed	 to	explain	how	 the	DP	population	commit	 to	
the	CD4	or	CD8	lineage,24	and	TCR	signal	strength	during	reper-
toire	selection	has	been	shown	to	influence	SP	lineage	commitment,	
with	 a	 stronger	 signal	 favouring	 differentiation	 to	 CD4	 SP.25-27	
The	fact	that	manipulation	of	the	Hh	signal	received	by	developing	
thymocytes	 influenced	 the	CD4/8	 lineage	decision	 therefore	 raised	
the	possibility	that	Hh	was	modulating	TCR	signal	strength,	and	in	
this	way	affecting	the	 lineage	decision.	Interestingly,	we	found	that	
cell	 surface	 expression	 of	 CD5,	 which	 correlates	 with	TCR	 signal	
strength,28	was	decreased	in	the	Lck-Gli2DN2	transgenic	thymocytes,	
and	after	treatment	of	WT	thymi	with	r-Shh.	This	reduction	in	cell	
surface	CD5	expression	therefore	supported	the	idea	that	the	reduced	
proportion	of	CD4	SP	cells	 found	 in	 the	Lck-Gli2DN2	transgenic,	
and	 after	 treatment	 of	 WT	 thymi	 with	 r-Shh,	 is	 a	 result	 of	 Hh	
signaling	acting	to	reduce	TCR	signal	strength.
Figure 1. Summary of Hedgehog pathway activity in CD4/8 lineage 
commitment, TCR repertoire selection and peripheral T cell activation. 
(A) Reduced Hh signaling (i.e., in Shh‑/‑ thymus) promotes CD4 lineage 
commitment resulting in increased CD4:CD8 ratio (left). In contrast increased 
Hh signaling (i.e., in transgenic Lck‑Gli2DN2 thymocytes with constitutively 
active Hh signaling, or in thymus explants treated in vitro with r‑Shh) results 
in reduced CD4:CD8 ratio (right). (B) Hh signaling negatively influences both 
positive and negative selection. Deletion of CD8 thymocytes expressing the 
transgenic TCR recognizing the male antigen HY (in the context of MHC class I) 
is impaired in Lck‑Gli2DN2 male thymus but enhanced in Shh‑/‑ male thymus 
(left). Positive selection of Lck‑Gli2DN2 CD8 cells expressing the HY‑TCR 
is also negatively affected in the female thymus whereas positive selec‑
tion of HY‑TCR transgenic thymocytes is promoted in Shh‑/‑ female thymus. 
(C) Hedgehog signaling antagonizes in vitro T cell activation. Proliferation 
and activation of peripheral Lck‑Gli2DN2 T cells was inhibited. (D) Proposed 
model for possible role of Hh signaling and T cell activation during tissue 
repair or tumor development. Damaged tissues or tumors might produce and 
secrete Hh proteins that can signal to lymphoid cells present. We predict that 
Hh pathway signaling would limit T cell activation in response to Hh secretion 
by damaged tissues and tumors. 
Hedgehog	in	TCR-Signaling
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To	 test	 this	hypothesis,	we	used	 the	HY-TCR	transgenic	model	
that	allowed	the	study	of	positive	and	negative	selection	of	CD8	SP	
cells.29	HY-TCR	 transgenic	T	 cells	 express	 a	TCR	 that	 recognises	
a	 male	 antigen,	 restricted	 by	 a	 Class	 I	 MHC	 molecule.	 In	 male	
HY	 mice,	 negative	 selection	 is	 highly	 efficient	 with	 deletion	 of	
the	male-reactive	CD8	and	DP	population.29	When	we	added	 the	
Lck-Gli2DN2	transgene	 to	male	mice	positive	 for	 the	HY-TCR	we	
found	a	small	population	of	HY-TCR	positive	(auto-reactive)	CD8	
SP	cells	that	had	escaped	deletion.12	The	HY-TCR	model	can	also	be	
used	to	assess	positive	selection	to	the	CD8	lineage	in	female	mice.29	
In	HY-TCR	females	with	the	Lck-Gli2DN2	transgene,	we	observed	
reduced	 positive	 selection	 of	 thymocytes	 expressing	 the	 transgenic	
TCR	to	the	CD8	SP	lineage	(Fig.	1B).
To	 confirm	 the	 physiological	 significance	 of	 this	 observation	
we	 analysed	 Shh	 deficient	 HY-TCR	 mice.	 Again,	 analysis	 of	 Shh	
deficiency	showed	the	opposite	effect	to	the	Lck-Gli2DN2	transgenic,	
with	more	efficient	deletion	in	males	and	increased	positive	selection	
in	 females.12	 The	 altered	 selection	 observed	 using	 the	 HY-TCR	
model	thus	showed	that	Shh	signaling	does	act	to	reduce	TCR	signal	
strength	 in	developing	thymocytes	during	TCR	repertoire	selection	
(Fig.	1B).
Shh	is	secreted	by	thymus	epithelial	cells	scattered	in	the	medulla	
and	 at	 the	 corticomedullary	 junction,2,6,9	 where	 TCR	 repertoire	
selection	 takes	 place.30	 Proximity	 to	 the	 Shh	 source	would	 dictate	
the	 strength	 of	TCR	 signal	 received	 by	 a	 given	 cell,	 allowing	 the	
architecture	of	the	thymus	to	influence	the	T	cell	repertoire	by	setting	
up	 a	 Hh	 gradient.	 As	 developing	 thymocytes	 move	 through	 the	
thymus	they	will	encounter	different	strengths	of	Shh	and	therefore	
the	outcome	of	TCR-ligation	for	positive	and	negative	selection	and	
CD4/CD8	lineage	decisions	will	be	dependent	on	their	position	in	
the	 thymus	 relative	 to	 the	 Shh	 signal.	Not	 all	medullary	 epithelial	
cells	express	Shh,2,6,9	so	it	is	likely	that	Shh-secreting-epithelial	cells	
are	specialised	for	particular	functions,	setting	up	‘niches’	to	promote	
positive	selection	and	commitment	to	the	CD8	lineage.
The	 way	 in	 which	 the	 transcriptional	 changes	 induced	 by	 Hh	
pathway	activation	modulate	the	TCR	signal	during	repertoire	selec-
tion	are	unknown,	and	further	investigation	is	required.
HH sIgNALINg ATTeNuATes peRIpHeRAL T-CeLL ACTIvATIoN 
ANd pRoLIFeRATIoN
On	antigen	recognition	in	the	periphery,	naïve	T	cells	are	stimu-
lated	 to	 clonally	 expand	 and	 differentiate	 into	 effector	 cells.	 This	
requires	 costimulation	 from	 antigen	 presenting	 cells	 (APC)	 and	
outcome	is	influenced	by	cytokines,	the	microenvironment	and	the	
strength	of	the	TCR	signal	received.31
Peripheral	T	cell	activation	and	proliferation	require	two	distinct	
signaling	 events.	 The	 TCR-CD3	 complex	 recognises	 antigen	
presented	 as	 peptide	 bound	 to	MHC	molecules	 on	 the	 surface	 of	
APC,	 and	 signals	 for	T	 cell	 activation.	 In	 addition,	 for	 full	T	 cell	
activation	a	costimulatory	signal	is	required,	transduced	by	binding	
of	CD28	on	the	T	cell	 to	CD80/CD86	on	the	APC.	These	events	
at	 the	 cell	 surface	 trigger	 intracellular	 signaling:	 Immunoreceptor	
tyrosine-based	activation	motifs	(ITAMs)	on	CD3	polypeptides	are	
phosphorylated	by	Lck	causing	recruitment	and	activation	of	ZAP-70.	
This	results	in	the	activation	of	multiple	signaling	cascades	including	
the	 MAPKinase,	 PKC,	 DAG	 Kinase,	 PI3Kinase	 and	 Calcineurin	
pathways,	 leading	 to	 the	 activation	 of	 transcription	 factors	 such	
as	 NFkB,	 NFAT	 and	 AP-1.	 These	 transcription	 factors	 bind	 to	
and	 activate	 transcription	 of	 genes	 necessary	 for	T	 cell	 activation,	
including	IL‑2.32-34	Secretion	of	IL-2,	a	potent	T	cell	growth	factor,	
and	 upregulation	 of	 IL-2	Receptor	 expression	 by	 the	T	 cell,	 allow	
autocrine	control	of	T	cell	proliferation.
The	 strength	 of	 signal	 transduced	 by	 the	 naïve	T	 cell	 on	TCR	
binding,	 as	 determined	 by	 antigen	 concentration	 and	 affinity	 and	
duration	of	 the	 interaction,	 influences	 further	T	cell	maturation	to	
specialised	effector	populations.35	The	interaction	between	the	T	cell	
and	the	APC	is	enhanced	by	adhesion	molecules	and	integrins.	These	
are	differentially	 expressed	depending	on	 the	 activation	 and	differ-
entiation	status	of	the	cell,	and	this	is	itself	regulated	by	cytokines	and	
signals	from	the	environment.36	The	final	outcome	of	the	activating	
signals	is	therefore	additionally	dependent	on	the	microenvironment	
of	both	 the	T	 cell	 and	 the	APC.	One	possible	 influence	on	T	 cell	
activation	could	be	Hh	 secretion	at	 the	 site	of	 activation.	The	 role	
of	 Shh	 in	 peripheral	 T	 cell	 activation	 and	 function,	 however,	 is	
controversial.6,37-39	We	 therefore	used	 the	Lck-Gli2DN2	 transgenic	
model	 to	 investigate	 the	effect	of	Hh	pathway	activation	on	T	cell	
activation.
In	 these	 experiments,	 in	 vitro	 activation	of	Lck-Gli2DN2	 trans-
genic	 T	 cells	 by	 ligation	 of	 TCR	 and	 CD28,	 attenuated	 T	 cell	
activation,	indicating	that	the	Hh	signaling	pathway	negatively	affects	
TCR-induced	T	cell	activation.12	The	presence	of	the	Lck-Gli2DN2	
transgene	also	seriously	affected	the	ability	of	T	cells	to	proliferate	in	
response	to	TCR	and	CD28	ligation12	(Fig.	1C).
Hh	 signaling	 has	 long	 been	 linked	 to	 proliferation,	 with	 an	
increase	 in	 Hh	 signaling	 generally	 found	 to	 enhance	 proliferation	
(for	example	in	the	development	of	limb,	taste	buds,	neural	crest	and	
thymus).4,6,10,40-44	 Consistent	 with	Hh	 promoting	 cell	 expansion,	
the	 first	Gli	 protein	 to	be	discovered,	Gli1,	was	 initially	 identified	
as	 an	 amplified	 gene	 and	 potential	 oncogene	 in	 a	 human	 glioma	
line,45,46	 and	 aberrant Hh signaling has been implicated in many	 	 	 	 	 	 	 	
common	 malignant	 tumors	 such	 as	 small	 cell	 lung	 carcinoma,	
pancreatic,	stomach	and	prostate	cancer.47-50
By	 analysis	 of	 loss-of-function	 mutants,	T	 lineage	 studies	 have	
shown	 that	 Hh	 signaling	 promotes	 proliferation	 of	 early	 DN	
thymocytes.6,10	In	contrast,	we	have	recently	found	that	constitutive	
activation	of	the	Hh	pathway	inhibits	the	proliferation	of	mature	T	
cells.12	The	effect	of	Hh	signaling	on	proliferation	has	also	appeared	
ambiguous	 in	other	 systems,	 in	particular	 in	 the	 retina.51	 In	 chick	
and	mouse	 retina	Shh	activation	 resulted	 in	 increased	BrdU	 incor-
poration	 suggesting	 that	Hh	 signaling	 promotes	 proliferation.52-54	
However,	Hh	mutant	Zebrafish	 exhibited	prolonged	 retinal	 prolif-
eration	due	to	the	inability	of	precursor	cells	to	exit	the	cell	cycle.55	
Recent	 work	 has	 suggested	 that	 Hh	 signaling	 may	 effect	 stem,	
progenitor	 and	 mature	 cells	 differently,	 with	 Hh	 signaling	 either	
promoting	proliferation	or	pushing	cells	out	of	the	cell	cycle	resulting	
in	reduced	proliferative	ability	depending	on	the	state	of	differentia-
tion	of	the	cell.56	The	T	cell	lineage	seems	to	provide	another	example	
of	Hh	activation	promoting	proliferation	of	the	progenitor	cell,	but	
limiting	the	proliferation	of	the	more	differentiated	mature	cell.	This	
difference	 in	 outcome	 could	 reflect	 differences	 in	 the	 intracellular	
context	 in	which	 the	Hh	 signal	 is	 transduced,	 leading	 to	 the	 tran-
scriptional	 regulation	 of	 distinct	 sets	 of	 target	 genes.	 Alternatively,	
the	inhibition	of	TCR-induced	mature	T	cell	proliferation	could	be	
the	result	of	reduction	in	TCR	signal	strength	by	the	pathway,	rather	
than	a	direct	effect	on	cell	cycle	regulator	target	genes.	While	early	
thymocyte	progenitors	must	expand	rapidly	to	fill	the	DP	pool,	and	
do	not	yet	express	a	TCR,	in	differentiated	T	cells	proliferation	must	
only	occur	as	a	consequence	of	appropriate	activation	in	response	to	
antigen,	after	stimulation	through	their	TCR.	Thus,	quite	different	
Hedgehog	in	TCR-Signaling
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processes	initiate	proliferation,	consistent	with	the	opposing	effects	of	
Hh	signaling	in	the	T	lineage,	in	accordance	with	maturity.
eRK pHospHoRyLATIoN ANd HH sIgNALINg
To	 dissect	 further	 the	 effect	 of	 Hh	 signaling	 on	 TCR	 signal	
strength,	peripheral	T	cell	activation	and	proliferation,	we	followed	
the	 kinetics	 of	MAPkinase	 pathway	 activation	 by	measuring	 ERK	
phosphorylation	 after	 TCR-induced	 activation	 by	Western	 blot.57	
Presence	 of	 the	 Lck-Gli2DN2	 transgene	 led	 to	 much	 delayed	 and	
reduced	levels	of	ERK	phosphorylation,	which	was	further	confirmed	
to	be	T-cell	specific	using	a	FACS-based	assay.12
This	 reduced	 ERK	 phosphorylation	 observed	 in	 our	 transgenic	
T	cells	is	of	particular	interest,	as	previous	accounts	of	Hh	pathway	
involvement	 in	 other	 tissues	 are	 often	 linked	 to	 improved	 ERK	
phosphorylation.58-61	 For	 example,	 addition	 of	 Shh	 during	 retinal	
regeneration,	 led	 to	an	 increase	 in	ERK	phosphorylation	 indirectly	
via	 the	 FGF/FGFR	 pathway.59	 The	 mechanism	 by	 which	 the	
transcriptional	events	induced	by	Hh	signaling	reduced	TCR-induced	
ERK	phosphorylation	is	unknown,	however	it	must	be	proximal	to	
TCR	ligation,	as	ERK	phosphorylation	is	an	immediate	consequence	
of	TCR	ligation.62
The	MAPKinase	pathway	is	a	key	regulator	of	cell	proliferation.57	
ERK	 activity	 must	 be	 sustained	 late	 into	 G1	 to	 enable	 successful	
S-phase	 entry63	 and	 inhibitors	 of	ERK	phosphorylation	have	been	
shown	 to	 inhibit	 the	 proliferation	 of	many	 cell	 types	 including	T	
cells.57	 A	 reduction	 in	 ERK	 phosphorylation	 leads	 to	 a	 decrease	
in	 the	 transcription	 of	 ubiquitous	mediators	 of	 cell	 cycle	 progres-
sion	and	in	the	case	of	activating	T	cells,	also	of	IL‑2 34,57,64	any	of	
which	could	lead	to	the	observed	attenuation	of	proliferation	in	the	
Lck-Gli2DN2	cells.	In	our	experiments,	addition	of	IL-2	to	activated	
cultures	restored	proliferation	of	Lck-Gli2DN2	T	cells	to	WT	levels,	
suggesting	 that	 a	 reduction	 in	 IL‑2	 gene	 transcription	 (caused	 by	
attenuated	MAPkinase	activity64)	is	responsible	for	the	proliferative	
defect.	The	fact	the	Lck-Gli2DN2	T	cells	can	proliferate	in	response	
to	 IL-2	 demonstrated	 that	 the	 transcriptional	 changes	 induced	 by	
active	Hh	signaling	did	not	inherently	inhibit	T	cell	division.
Thus,	we	favour	a	model	in	which	the	decreased	proliferation	and	
ERK	activation	of	mature	T	cells	on	TCR	ligation,	caused	by	consti-
tutive	Hh	signaling,	is	a	consequence	of	reduced	TCR	signal	strength	
mediated	by	Hh-dependent	transcription,	rather	than	a	direct	effect	
of	Hh	on	the	cells’	proliferation	per	se.
ImpLICATIoNs FoR ImmuNITy ANd dIseAse
Modulation	of	TCR	signal	 strength	by	Hh	has	profound	 impli-
cations	 for	 immunity.	 Presence	 of	 Hh	 would	 alter	 the	 threshold	
required	for	T	cell	activation,	and	therefore	determine	the	outcome	
of	the	naïve	T	cell’s	interaction	with	antigen,	with	consequences	for	
anergy,	regulation,	tolerance	and	inflammation.	This	has	significance	
for	immune	responses,	as	localised	sources	of	Hh	in	the	T	cell	micro-
environment	could	influence	the	outcome	of	TCR	signaling.	In	the	
future,	it	will	be	important	to	test	this	hypothesis	in	mouse	models	
and	in	human	disease.
Hh	proteins are expressed in skin, gut and lung.	 	 	 	 	 	 	 1	These	 tissues	
are	 subject	 to	 recurrent	 immune	 challenge,	 as	 they	 are	 the	 sites	 of	
entry	of	 external	 pathogens	 from	 the	 environment,	 from	 food	 and	
air.	They	are	also	subject	to	inflammatory	and	autoimmune	diseases.	
Hh	 expression	 in	 these	 tissues	during	 renewal	 or	 remodelling	 after	
infection	 or	 tissue-damage	 could	 function	 to	 dampen	 down	 the	
immune	response,	protecting	against	the	induction	of	inflammatory	
or	autoimmune	diseases	(Fig.	1D).	By	reducing	lymphocyte	responses	
to	antigen,	Hh signaling may also be involved in immune evasion by	 	 	 	 	 	 	 	 	 	
tumours.	Aberrant	Hh	signaling	is	common	in	many	cancers5,17	and	
secretion	of	Hh	by	a	tumour	could	potentially	diminish	the	immune	
response	to	that	tumour,	allowing	escape	from	immune	surveillance.
Changes	 in	Hh	 signaling	 could	 be	 involved	 in	 the	 aetiology	 of	
autoimmune	disease	and	mutations	 in	components	of	 the	pathway	
could	increase	disease	susceptibility,	either	by	allowing	self-reactive	T	
cells	to	escape	negative	selection	in	the	thymus,	or	by	reducing	the	
TCR	 signal	 threshold	 for	mature	T	 cell	 activation.	 In	 the	 thymus,	
mutations	 increasing	 either	 Shh	 secretion	 by	 epithelial	 cells,	 or	
signal	 interpretation	by	thymocytes,	would	allow	those	self-reactive	
clones	 that	would	 normally	 be	 deleted,	 to	mature	 and	 escape	 into	
the	peripheral	lymphoid	organs,	potentially	leading	to	autoimmune	
disease.	 In	 contrast,	 mutations	 leading	 to	 decreased	 Hh	 signal	 in	
peripheral	 T	 cells	 (via	 decreased	 secretion	 in	 the	 environment	 or	
signal	 interpretation	by	 the	T	cell)	would	 increase	 the	TCR	signal,	
potentially	leading	to	inappropriate	T	cell	activation.
The	role	of	Hh	signaling	in	T	cells	(and	immunity)	is	a	new	field,	
so	 there	 is	 still	much	work	 to	be	done	 to	dissect	 its	 functions	 and	
gain	insight	into	the	molecular	mechanisms.	It	will	be	important	to	
understand	how	Hh	modulates	 the	TCR	 signal,	 and	 to	 investigate	
the	 effect	 of	Hh	 gradient	 on	 the	 signal.	 It	 will	 also	 be	 interesting	
to	 test	 if	Hh	 signaling	 regulates	 other	 components	of	 the	 immune	
system.
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